SPATS2 and colorectal carcinoma: The correlation found in CRC samples was further confirmed by analyzing SPATS2 levels in the xenograft tumours, where knockdown of SNHG5 resulted in a significant decrease in SPATS2 mRNA levels (Fig. 5d).